regulatory intelligence US Canada - Arora 297 Consultancy

2026 Regulatory Compliance Forecast: Key Trends for Pharmaceuticals and Medical Devices

Mar 16, 2026 0 Comments

The 2026 forecast highlights major regulatory changes in pharmaceuticals and medical devices, including FDA QMSR updates, Health Canada UDI phases, AI/ML SaMD rules, and cybersecurity, urging proactive compliance and expert…

Decoding Recent FDA and Health Canada Updates: Implications for Pharmaceutical Product Approvals

Feb 16, 2026 0 Comments

FDA and Health Canada updates tighten timelines, increase evidence demands, and require eCTD v4.0 submissions. Leverage accelerated pathways (PDUFA, NOC/c) and ICH Q12 for post-approval management.

2026 Regulatory Compliance Forecast: Key Trends for Pharmaceuticals and Medical Devices

Decoding Recent FDA and Health Canada Updates: Implications for Pharmaceutical Product Approvals

You Missed

Ingredient and Claim Reviews: The Backbone of Cosmetic Compliance in the US and Canada

Staying Audit-Ready After Approval: A Practical Guide for Pharma, Devices, and Cosmetics

What Decision-Makers Should Know Before Entering Regulated Markets: A Practical Readiness Playbook

Building Your US and Canadian Regulatory Roadmap: A Step-by-Step Guide

Arora 297 Consultancy

Quick Links

Contact Us